POSTOPERATIVE ADJUVANT CONCURRENT CHEMO-RADIOTHERAPY IMPROVES SURVIVAL RATES FOR HIGH RISK, EARLY STAGE CERVICAL CANCER PATIENTS FOLLOWING RADICAL HYSTERECTOMY AND PELVIC LYMPH NODE DISSECTION